Wells Fargo: OK for Bausch’s Bryhali expected by tomorrow’s PDUFA date

Wells Fargo says approval for Bausch’s Bryhali expected by tomorrow’s PDUFA date. Wells Fargo analyst David Maris noted that the PDUFA date for Health’s Bryhali for psoriasis is tomorrow, October 5, and it is expected that the company will receive FDA approval. He reads the fact that the company has already gone live with a Bryhali webpage promoting the message “Coming Soon” as a sign of Bausch’s confidence in the approval, Maris added. He maintains an Underperform rating on Bausch Health shares.
https://thefly.com/landingPageNews.php?id=2800025